Alterity Therapeutics Ltd. (ATHE)
3.36
+0.07
(+2.13%)
USD |
NASDAQ |
Dec 09, 16:00
3.34
-0.02
(-0.60%)
After-Hours: 20:00
Alterity Therapeutics Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Kazia Therapeutics Ltd. | -- |
| Immutep Ltd. | -- |
| Propanc Biopharma, Inc. | 10.92M |
| Mesoblast Ltd. | 2.445B |
| Immuron Ltd. | -- |
Enterprise Value Related Metrics
| Earnings Yield | -22.16% |
| Normalized Earnings Yield | -24.08 |